Before you continue to ppPLUS

Cookies

ppPLUS use cookies essential for this site to function well. Learn about our use of cookies, and collaboration with selected social media and trusted analytics partners here.

Privacy & Terms and Conditions

Please review our Privacy Policy and Terms & Conditions, before you start using ppPLUS.

Entity Shareholding

: Wacker Biotech US Inc.

Shareholder: Wacker Chemical Corporation
Scenario: SS | Default Shareholder Scenario
Percentage: 100.00%
From: 01/2021
To: 12/2050
Consolidation: U
Multiple Shareholders
Document: https://www.wacker.com/cms/en-de/about-wacker/wacker-at-a-glance/production-sites/san-diego.html
Description: In 2021, WACKER strengthened its biopharma business with the acquisition of Genopis, a pharmaceutical contract manufacturer of plasmid DNA (pDNA) headquartered in San Diego, California.

System Info

User: Braun, Uwe
Added: 11/1/2022 1:44 PM